Improving Lives Through
Diagnostic and
Therapeutic Solutions
AXIM is a vertically integrated research and development company focused on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19)
Improving Lives Through
Diagnostic and
Therapeutic Solutions
AXIM’s proprietary research intends to find new ways to diagnose and treat cancer as well as other conditions through laboratory-derived cannabinoid and oncological therapeutics.
COVID-19 TESTING
CLINICAL therapeutics
AXIM’s clinical therapeutic research focuses around an enzyme called “QSOX1” where the company hopes to bring a novel oncology drug to market
CANCER dIAGNOSTICS
AXIM is in development of various “point-of-care” diagnostic testing products designed for the early detection of cancer
The Latest On Our Research
A face mask coated in a biological mousetrap for the virus? Just one of AXIM’s inventions.
SAN DIEGO (KGTV) — A small San Diego biotech is trying to give face masks an added layer of defense by spraying the liner with a biological bait designed to be a mousetrap for the coronavirus. AXIM Biotechnologies is also developing a next-generation rapid antibody...
Making a better facemask, Axim Biotech looks to be a leader protecting people from COVID-19
Axim Biotech (OTCQB: AXIM) CEO John Huemoeller joined Steve Darling from Proactive with news the company is working on a number of initiatives around protecting people from COVID-19. One of those is a much better facemask and Huemoeller explains how. Huemoeller also...
World’s First Face Mask Designed to Capture and Deactivate SARS-CoV-2 Could Lower COVID-19 Infection Rate
By HospiMedica International staff writers Posted on 30 Sep 2020 The outbreak of respiratory infection based pandemic diseases like COVID-19 is fueling global demand for face masks among frontline health workers such as first responders, nurses, and medical...